Status:
UNKNOWN
Efficacy of Manuka Honey Nano-Formulation in the Treatment of Acne Vulgaris
Lead Sponsor:
Al-Azhar University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The present study aims to manufacture manuka honey-loaded nano-formulation using natural materials as a potent tissue-healing remedy and compare it to commercially available antimicrobial therapy in o...
Detailed Description
It was found that patients with acne suffer from lower self-esteem, depression, anxiety, and social isolation as a result of papules, pustules, nodules, cysts, and scarring. Moreover, a common complic...
Eligibility Criteria
Inclusion
- Mild to moderate acne vulgaris patients.Patients will be assessed for severity of acne by Global acne grading system (GAGS).
- Age of patients: 18-40 years.
- Sex: both sexes.
Exclusion
- Pregnancy and lactation.
- severe acne vulgaris.
- exogenous acne as industrial or cosmetic causes.
- Patients with photodermatitis or allergic dermatitis.
- serious or systemic illnesses such as liver and renal dysfunction.
- Patients with radiotherapy, cryotherapy, cutaneous malignant tumors, and patients suffer from mental illnesses.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 11 2024
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06175819
Start Date
January 1 2024
End Date
September 11 2024
Last Update
December 19 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.